Fresenius Kabi Recalls Mislabelled Midazolam Syringes Containing Ondansetron
Fresenius Kabi is recalling 203,136 syringes of Midazolam Injection that were mislabeled and actually contain Ondansetron Injection.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA has classified this recall as Class I, which meets the rubric criteria for a Critical severity score.
Plain-English summary
Fresenius Kabi USA, LLC is recalling 203,136 syringes of Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL). The product is packaged in 24 x 2 mL prefilled single-use syringes per carton and is distributed nationwide in the USA. The specific lot number is 6400048.
The recall was initiated due to a labeling mix-up. The blister packages are labeled as Midazolam Injection, USP, 2 mg / 2 mL, but they actually contain syringes of Ondansetron Injection, USP, 4 mg / 2 mL. This discrepancy means that healthcare providers or patients relying on the label may administer the wrong medication.
Healthcare facilities and consumers who have this product should stop using it and contact Fresenius Kabi USA, LLC for instructions on how to return the product. The FDA has classified this recall as Class I, indicating a reasonable probability that use of the product may cause serious adverse health consequences or death.
The recalled product
- Product
- MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)
- Brand
- MIDAZOLAM
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Injection
- Affected units
- 203,136
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 6400048
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · MIDAZOLAM
- SevereFresenius Kabi Recalls Midazolam Injection Due to Impurities
FDA (Drugs) · 2017-02-08
- SevereFresenius Kabi Recalls Midazolam Hydrochloride Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2014-12-17
Same manufacturer · Fresenius Kabi USA, LLC
See all →- SevereFresenius Kabi Recalls Tyenne Injection Due to Glass Particles
FDA (Drugs) · 2026-09-02
- CriticalFresenius Kabi Recalls Morphine Syringes Due to Labeling Error
FDA (Drugs) · 2026-08-26
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02